A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia

Blood

Volumn 117, Issue 1, 2011, Pages 242-245

  Such, Esperanza ^a   Cervera, José ^a   Valencia, Ana ^a   Barragán, Eva ^a   Ibañez, Mariam ^a   Luna, Irene ^a   Fuster, Óscar ^a   Perez Sirvent, Maria Luz ^a   Senent, Leonor ^a   Sempere, Amparo ^a   Martinez, Jesús ^a   Martín Aragonés, Guillermo ^a   Sanz, Miguel A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CYTARABINE; D DIMER; IDARUBICIN; NUCLEOPORIN 98; RETINOIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; B LYMPHOCYTE; BONE MARROW; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; GENE FUSION; GENE TRANSLOCATION; HUMAN; IMMUNOPHENOTYPING; KARYOTYPING; MALE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RECEPTOR GENE; RETINOID ACID RECEPTOR GAMMA GENE; T LYMPHOCYTE;

EID: 78650979126     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-06-291658     Document Type: Article

References (12)

1. La Starza R, Brandimarte L, Pierini V, et al. A NUP98-positive acute myeloid leukemia with a t(11;12)(p15;q13) without HOXC cluster gene involvement. Cancer Genet Cytogenet. 2009;193(2):109-111.
2. Romana SP, Radford-Weiss I, Ben Abdelali R, et al. NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique Hématologique. Leukemia. 2006;20(4):696-706.
3. Marinelli A, Bossi D, Pelicci PG, Minucci S. A redundant oncogenic potential of the retinoic receptor (RAR) a, b and c isoforms in acute promyelocytic leukemia. Leukemia. 2007;21(4):647-650. (Pubitemid 46444547)
4. Montesinos P, Bergua JM, Vellenga E, et al. Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors. Blood. 2009;113(4):775-783.
5. Falini B, Flenghi L, Fagioli M, et al. Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). Blood. 1997;90(10):4046-4053.
6. Shaffer LG, Tommerup N, eds. ISCN 2005: An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S. Karger; 2005.
7. Bolufer P, Barragán E, Sánz MA, et al. Preliminary experience in external quality control of RT-PCR PML-RARalpha detection in promyelocytic leukemia. Leukemia. 1998;12(12):2024-2028.
8. Gu BW, Wang Q, Wang JM, et al. Major form of NUP98/HOXC11 fusion in adult AML with t(11; 12)(p15;q13) translocation exhibits aberrant trans-regulatory activity. Leukemia. 2003;17(9):1858-1864.
9. La Starza R, Trubia M, Crescenzi B, et al. Human homeobox gene HOXC13 is the partner of NUP98 in adult acute myeloid leukemia with t(11; 12)(p15;q13). Genes Chromosomes Cancer. 2003;36(4):420-423. (Pubitemid 36314526)
10. Lam DH, Aplan PD. NUP98 gene fusions in hematologic malignancies. Leukemia. 2001;15(11):1689-1695.
11. Hussey DJ, Dobrovic A. Recurrent coiled-coil motifs in NUP98 fusion partners provide a clue to leukemogenesis. Blood. 2002;99(3):1097-1098. (Pubitemid 34525582)
12. Marinelli A, Bossi D, Pelicci PG, and Minucci S. Redundant function of retinoic acid receptor isoforms in leukemogenesis unravels a prominent function of genome topology and architecture in the selection of mutagenic events in cancer. Leukemia. 2009;23(2):417-419.